Frier Levitt, Author at Frier Levitt

Lessons Learned from the First Wave of COVID-19: How to Navigate the Second Wave and Implement Lasting Changes to Benefit your Practice On Demand Webinar Replay

Frier Levitt April 15, 2021

Frier Levitt is proud to offer a complimentary webinar replay recapping the lessons healthcare practices should learn from the first wave of the COVID-19 pandemic that could help them both navigate the second wave and implement meaningful changes... Read More

COVID-19 Resources | Webinars

Patient Right of Access to Medical Records Remains OCR Enforcement Priority

Arielle T. Miliambro, Esq., Jonian Rafti, Esq. and Frier Levitt March 3, 2021

The Department of Health and Human Services Office for Civil Rights (“OCR”) continues to bring enforcement actions against entities it alleges have infringed on a patient’s right to timely access their records in violation of the Health... Read More

Blogs & Articles | Healthcare | Healthcare Law | HIPAA Compliance

NJ Physician Sentenced to 33 Months in a $24 Million Telehealth Compounded Medication Scheme

Arielle T. Miliambro, Esq., Jonian Rafti, Esq. and Frier Levitt March 1, 2021

On January 27, 2021, the U.S. Attorney’s Office for the District of New Jersey announced that a New Jersey physician was sentenced to 33 months in prison for his role in a telehealth scheme that served to prescribe expensive compounded medications... Read More

Blogs & Articles | Telehealth and Telemedicine

Former UnitedHealth Chief and Federal Prosecutor Joins Frier Levitt Anthony Mahajan, Esq. to Chair Firm’s Expanding White Collar Defense & Government Investigations Practice

Anthony J. Mahajan, Esq. and Frier Levitt March 1, 2021

We are excited to welcome our newest Partner, Anthony Mahajan, Esq., who joins the Firm’s Litigation and Regulatory Departments and will serve as the Chair of our White Collar Defense & Government Investigations Practice. Anthony brings to... Read More

Blogs & Articles | White Collar Defense and Government Investigation

How Physicians Can Create a Data Warehouse and Utilize Their Data More Effectively

Daniel B. Frier, Esq. and Frier Levitt February 25, 2021

As we’ve said before, “if you don’t have control over your data, you don’t have control over your practice.” But what exactly does that mean and how can physicians use both structured and unstructured data to maximize its value? Frier... Read More

Data Transactions | Videos

The Surprise Act: Surprise Changes to Out of Network Medical Billing

Guillermo J. Beades, Esq., Abdul J. Roberts, Esq. and Frier Levitt February 19, 2021

On December 27, 2020, Congress enacted, and the President signed, H.R. 3630, the Surprise Act (“Act”), which will take effect on January 1, 2022. This Act expands restrictions on charging health care plan holders out-of-network rates for certain... Read More

Administrative and Insurance Defense Law | Blogs & Articles

Why You Need a Healthcare Attorney to Represent You in a Medicare Audit and Appeal

Theresa M. DiGuglielmo, Esq., Guillermo J. Beades, Esq. and Frier Levitt February 18, 2021

One: According to Supreme Court Justice Antonin Scalia, “Administrative Law is not for sissies.” Medicare rules in general, and the appeals process, in particular, are codified in a complex body of regulations known as administrative law.... Read More

Blogs & Articles | Medicare, Medicaid, and Other Commercial Payor Audits & Appeals

Why Antitrust Enforcement will Matter to Your Practice in 2021 and Beyond

Daniel B. Frier, Esq., Andreas Stargard, Esq. and Frier Levitt February 9, 2021

*As seen in Medical Economics* There are some persuasive incentives for your practice to consider implementing or reviewing its antitrust compliance right now. Every four years, like clockwork, law firms feel the urge to remind their clients... Read More

Antitrust Review and Compliance

McKinsey Opioid Settlement Highlights Broad Reach of Laws Affecting Healthcare and Life Sciences Industries

Arielle T. Miliambro, Esq., Jonian Rafti, Esq. and Frier Levitt February 4, 2021

On February 4, 2021, the Attorneys General of 47 states announced a $573 million joint settlement with the global consulting firm McKinsey & Company. The settlement, in which McKinsey did not admit wrongdoing, was predicated on McKinsey’s... Read More

Blogs & Articles | Drug and Device Advertising, Marketing & Promotion Legal Review | Regulatory Compliance, including FDA, DEA and HIPAA | White Collar Criminal Defense & Government Investigations

Lessons Learned from the First Wave of COVID-19: How to Navigate the Second Wave and Implement Lasting Changes to Benefit your Practice

Guillermo J. Beades, Esq., Wiks Moffat, CHC, Jim Tudor, PCA, CPC and Frier Levitt February 1, 2021

by Guillermo Beades, Esq. of Frier Levitt, LLC, Wiks Moffat, CHC, of HealthCare Compliance Network, LLC, and Jim Tudor, PCA, CPC, of HealthCare Compliance Network, LLC When the COVID-19 pandemic reached our shores, it instantly changed the way we... Read More

Blogs & Articles | COVID-19 Resources | Telehealth and Telemedicine

Author: Frier Levitt